EGFRvIII Mrna Detection in the Serum of Patients with Hepatocellular Carcinoma
Min Zhou,Bangdong Gong,Jianren Gu,Zonghai Li
DOI: https://doi.org/10.1111/j.1478-3231.2010.02233.x
IF: 8.754
2010-01-01
Liver International
Abstract:Liver InternationalVolume 30, Issue 6 p. 925-927 EGFRvIII mRNA detection in the serum of patients with hepatocellular carcinoma Min Zhou, Min Zhou State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Medical School of Shanghai Jiaotong University, Shanghai, China *Contributed equally.Search for more papers by this authorBangdong Gong, Bangdong Gong Ruijin Hospital, Medical School of Shanghai Jiaotong University, Shanghai, China *Contributed equally.Search for more papers by this authorJianren Gu, Jianren Gu State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Medical School of Shanghai Jiaotong University, Shanghai, ChinaSearch for more papers by this authorZonghai Li, Zonghai Li State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Medical School of Shanghai Jiaotong University, Shanghai, ChinaSearch for more papers by this author Min Zhou, Min Zhou State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Medical School of Shanghai Jiaotong University, Shanghai, China *Contributed equally.Search for more papers by this authorBangdong Gong, Bangdong Gong Ruijin Hospital, Medical School of Shanghai Jiaotong University, Shanghai, China *Contributed equally.Search for more papers by this authorJianren Gu, Jianren Gu State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Medical School of Shanghai Jiaotong University, Shanghai, ChinaSearch for more papers by this authorZonghai Li, Zonghai Li State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Medical School of Shanghai Jiaotong University, Shanghai, ChinaSearch for more papers by this author First published: 31 May 2010 https://doi.org/10.1111/j.1478-3231.2010.02233.xCitations: 10 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Pedersen MW, Meltorn M, Damstrup L, Poulsen HS. The type III epidermal growth factor receptor mutation. Biological significance and potential target for anti-cancer therapy. Ann Oncol 2001; 12: 745– 60. 2 Wang H, Jiang H, Zhou M, et al. Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma. Cancer Lett 2009; 279: 30– 8. 3 Ou C, Wu FX, Luo Y, et al. Expression and significance of epidermal growth factor receptor variant type III in hepatocellular carcinoma. Aizheng Chin J Cancer 2005; 24: 166– 9. 4 Miura N, Shiota G, Nakagawa T, et al. Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma. Oncology 2003; 64: 430– 4. 5 Silva HA, Abraul E, Raimundo D, et al. Molecular detection of EGFRvIII-positive cells in the peripheral blood of breast cancer patients. Eur J Cancer 2006; 42: 2617– 22. 6 Ng EK, Tsui NB, Lam NY, et al. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin Chem 2002; 48: 1212– 7. Citing Literature Volume30, Issue6July 2010Pages 925-927 ReferencesRelatedInformation